Clinical Trial Update: Desipramine in Infantile Neuroaxonal Dystrophy (INAD). [Phase 4]

View source ↗

Summary

Phase 4 trial of desipramine for Infantile Neuroaxonal Dystrophy was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infantile Neuroaxonal Dystrophy

Drugs mentioned

• Desipramine (desipramine)

Snippet

Sponsor: Duke University | Conditions: Infantile Neuroaxonal Dystrophy | Phase 4 | Status: TERMINATED | Results posted: 2020-10-14